Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Bracco Imaging S.p.A. is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single active matter is the only prosecution task currently identified for the company. The workload is handled by 1 distinct examiner and is situated within 1 distinct art unit, indicating a narrow technical focus for the company's current patent applications. This concentration allows for a very specific prosecution strategy tailored to the requirements of a single administrative unit.
The busiest examiner for the portfolio is O DELL, DAVID K, who is currently reviewing 1 busiest examiner pending office action. As this 1 pending office action is the only one in the portfolio, the examiner's specific feedback will be the deciding factor for the company's immediate patent goals. The fact that there is only 1 distinct examiner involved means that the company does not currently have to manage multiple examiner styles or conflicting requirements across different art units. Practitioners should prioritize the specific technical standards of the 1 distinct art unit involved in this Biotechnology & Pharmaceuticals matter.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| O DELL, DAVID K | 1 | 57.7% | +36.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18017939 | MANUFACTURING OF DIMERIC CONTRAST AGENTS | O DELL, DAVID K | 70d overdue |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18017939 | MANUFACTURING OF DIMERIC CONTRAST AGENTS | O DELL, DAVID K | 1621 | §103§112DP | Final Rejection | 70d overdue | Pending | Jan 25, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial